Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

86.900
+2.0002.36%
Volume:270.70K
Turnover:23.33M
Market Cap:150.77B
PE:162.44
High:86.900
Open:86.900
Low:86.900
Close:84.900
52wk High:109.100
52wk Low:36.600
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:- -
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.535
ROE:5.01%
ROA:1.49%
PB:6.84
PE(LYR):162.44
PS:10.16

Loading ...

Morgan Stanley Reinitiates Coverage on Innovent Bio with "Overweight" Rating, Sees Biotech Catalysts Concentrated in Second Half

Stock News
·
Mar 04

Innovent Biologics Says Lymphoma Drug Bags China Nod for Additional Indication

MT Newswires Live
·
Mar 02

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

THOMSON REUTERS
·
Mar 02

BRIEF-Innovent Biologics Says Jaypirca Received Approval By NMPA China

Reuters
·
Feb 27

Innovent Biologics, Inc. (1801) Announces NMPA Approval of Jaypirca for Recurrent CLL/SLL

Bulletin Express
·
Feb 27

INNOVENT BIO's Pirtobrutinib Gains Approval in China for Relapsed or Refractory CLL/SLL

Stock News
·
Feb 27

Innovent Biologics - Jaypirca Received Approval by Nmpa China

THOMSON REUTERS
·
Feb 27

Innovent Says China NMPA Approves Jaypirca for Relapsed or Refractory CLL/SLL

Reuters
·
Feb 27

A Look At Innovent Biologics (SEHK:1801) Valuation After Progress In Phase 3 IBI354 Breast Cancer Trial

Simply Wall St.
·
Feb 17

Innovent Biologics Doses First Patient in Phase 3 Trial of Novel HER2 ADC for Advanced Breast Cancer

Reuters
·
Feb 13

JPMorgan Increases Stake in Innovent Bio by 585,900 Shares at HK$79.23 Each

Stock News
·
Feb 12

Innovent Biologics Forges Seventh Partnership with Eli Lilly in $8.85 Billion Deal

Deep News
·
Feb 10

Innovent Appears on Track to Meet 2027 Revenue Target -- Market Talk

Dow Jones
·
Feb 10

INNOVENT BIO Shares Climb Over 5% Again Following Seventh Global Partnership with Eli Lilly; Goldman Sachs Sees Undervaluation

Stock News
·
Feb 10

Asian Market Stocks Trading Below Estimated Value In February 2026

Simply Wall St.
·
Feb 10

Hong Kong Stocks Rebound Strongly During Window Period as New AI Models Provide Positive Boost

Stock News
·
Feb 09

Innovent, Pop Mart Lead Hang Seng Index Higher -- Market Talk

Dow Jones
·
Feb 09

Bank of America Securities Reaffirms "Buy" Rating on Innovent Biologics with HK$113.5 Target Price

Stock News
·
Feb 09

CICC Maintains Outperform Rating on Innovent Biologics with HK$118.3 Target Price

Stock News
·
Feb 09

INNOVENT BIO Shares Surge Over 4% on Strategic Collaboration with Eli Lilly Potentially Worth $8.85 Billion

Stock News
·
Feb 09